• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

DEAR MR. NAITO....





To all Eisai employees:

Stop calling Mr. Naito to step up and take actions. He is as incompetent as LC. He is super mad because of the failures. But he doesn't know how to fix it.

You all should contact the reports who wrote the Eisai's failure of Eritoren trial. the following are the contact info:

To contact the reporter on this story: Kanoko Matsuyama in Tokyo at kmatsuyama2@bloomberg.net.

To contact the editor responsible for this story: Jason Gale at j.gale@bloomberg.net.